首页> 外国专利> Antibrucellosis vaccine - from cultures contg brucella and brucella antiserum

Antibrucellosis vaccine - from cultures contg brucella and brucella antiserum

机译:抗布鲁氏菌病疫苗-来源于布鲁氏菌和布鲁氏菌抗血清的培养物

摘要

Microorganisms, esp. Brucells, are cultured serially in a medium contg. the corresponding anti-serum in order to modify the pheotype but not the genotype. The product is deactivated by formaldehyde and may be treated with sodium lauryl sulphate to give a product which does not contain agglutinins which interfere with the diagnosis of the particular disease. In an example highly pathogenic Brucella Melitensis was isolated and cultured 10-30 times on tryptose-agar contg. 10% anti serum titrating at 2000 U/ml. This strain was lyophilised and was used to prepare vaccine on a prodn. scale. From this stock inoculum 2-10 subcultures were carried out, generally in a liq. medium contg. anti-specific serum.
机译:微生物,特别是Brucells在连续的培养基中连续培养。相应的抗血清以修饰表型而不是基因型。该产物被甲醛减活,可以用月桂基硫酸钠处理,得到的产物不含凝集素,这些凝集素干扰了特定疾病的诊断。在一个实例中,分离出高致病性的布鲁氏布鲁氏菌,并在胰蛋白琼脂琼脂上培养10-30次。 10%抗血清滴定于2000 U / ml。将该菌株冻干并用于制备产品。规模。从这种原种接种物中,通常在液中进行2-10次亚培养。中续抗特异性血清。

著录项

  • 公开/公告号FR2176482A1

    专利类型

  • 公开/公告日1973-11-02

    原文格式PDF

  • 申请/专利权人 BELLON LABORATOIRESFR;

    申请/专利号FR19720009684

  • 发明设计人

    申请日1972-03-20

  • 分类号A61K23/00;C12K3/00;C12K5/00;

  • 国家 FR

  • 入库时间 2022-08-23 06:39:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号